Laddar...
Mortality benefits from implantable cardioverter-defibrillator therapy are not restricted to patients with remote myocardial infarction: an analysis from the Sudden Cardiac Death in Heart Failure Trial (SCD-HeFT)
BACKGROUND: The implantable cardioverter-defibrillator (ICD) is an effective therapy for preventing sudden cardiac death (SCD) in patients with prior myocardial infarction (MI) and reduced left ventricular function; however, the optimal timing of ICD implantation after MI remains unknown. OBJECTIVE:...
Sparad:
| Huvudupphovsmän: | , , , , , , , |
|---|---|
| Materialtyp: | Artigo |
| Språk: | Inglês |
| Publicerad: |
2010
|
| Ämnen: | |
| Länkar: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4165645/ https://ncbi.nlm.nih.gov/pubmed/21109025 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.hrthm.2010.11.033 |
| Taggar: |
Lägg till en tagg
Inga taggar, Lägg till första taggen!
|